Title | Precursor central memory versus effector cell fate and naïve CD4+ T cell heterogeneity. |
Publication Type | Journal Article |
Year of Publication | 2024 |
Authors | Deep D, Gudjonson H, Brown CC, Rose SA, Sharma R, Iza YAPaucar, Hong S, Hemmers S, Schizas M, Wang Z-M, Chen Y, Wesemann DR, Pascual V, Pe'er D, Rudensky AY |
Journal | J Exp Med |
Volume | 221 |
Issue | 10 |
Date Published | 2024 Oct 07 |
ISSN | 1540-9538 |
Keywords | Animals, CD4-Positive T-Lymphocytes, Cell Differentiation, Humans, Immunologic Memory, Interferon Type I, Lymphocyte Activation, Memory T Cells, Mice |
Abstract | Upon antigenic stimulation, naïve CD4+ T cells can give rise to phenotypically distinct effector T helper cells and long-lived memory T cells. We computationally reconstructed the in vivo trajectory of CD4+ T cell differentiation during a type I inflammatory immune response and identified two distinct differentiation paths for effector and precursor central memory T cells arising directly from naïve CD4+ T cells. Unexpectedly, our studies revealed heterogeneity among naïve CD4+ T cells, which are typically considered homogeneous save for their diverse T cell receptor usage. Specifically, a previously unappreciated population of naïve CD4+ T cells sensing environmental type I IFN exhibited distinct activation thresholds, suggesting that naïve CD4+ T cell differentiation potential may be influenced by environmental cues. This population was expanded in human viral infection and type I IFN response-lined autoimmunity. Understanding the relevance of naïve T cell heterogeneity to beneficial and maladaptive T cell responses may have therapeutic implications for adoptive T cell therapies in cancer immunotherapy and vaccination. |
DOI | 10.1084/jem.20231193 |
Alternate Journal | J Exp Med |
PubMed ID | 39321257 |
PubMed Central ID | PMC11448869 |
Grant List | T32GM007739 / GM / NIGMS NIH HHS / United States R01 AI139538 / AI / NIAID NIH HHS / United States U54-CA209975 / CA / NCI NIH HHS / United States T32 AI007306 / AI / NIAID NIH HHS / United States R01 AI121394 / NH / NIH HHS / United States R01 A1034206 / / National Institute of Allergy and Infectious Diseases / P30 CA008748 / CA / NCI NIH HHS / United States R01 AI121394 / AI / NIAID NIH HHS / United States / WT_ / Wellcome Trust / United Kingdom P30CA008748 / / Memorial Sloan Kettering / / / Weill Cornell / / / Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center / WT201483/Z/16/Z / WT_ / Wellcome Trust / United Kingdom / HHMI / Howard Hughes Medical Institute / United States F30 AI154660 / AI / NIAID NIH HHS / United States T32 GM007205 / GM / NIGMS NIH HHS / United States R25 GM130494 / GM / NIGMS NIH HHS / United States T32 GM007739 / GM / NIGMS NIH HHS / United States U54 CA209975 / CA / NCI NIH HHS / United States / / Parker Institute for Cancer Immunotherapy / |
Submitted by est4003 on November 5, 2024 - 1:39pm